PaQ® Insulin Delivery Device

DEVICE2 trials

Sponsors

CeQur Corporation

Conditions

Type 2 Diabetes Mellitus

Unknown Phase

A Prospective Observational Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus

TerminatedNCT02158078

CeQur CorporationType 2 Diabetes Mellitus

Start: 2014-06-30End: 2014-11-30Updated: 2016-07-26

A Study to Assess Insulin Delivery With PaQ® in Patients With Type 2 Diabetes Mellitus

CompletedNCT02419859

CeQur CorporationType 2 Diabetes Mellitus

Start: 2015-02-28End: 2015-11-30Updated: 2016-07-26

Related Papers

Improved glycaemic control and treatment satisfaction with a simple wearable 3‐day insulin delivery device among people with Type 2 diabetes

Diabetic Medicine2018-06-1117 citations